Polaris AI Pharma Corp. engages in the manufacture and supply of pharmaceutical ingredients and fine chemicals. Its products include treatment of alcoholism, anti-inflammatory, analgesics, muscle relaxant, antiseptic, antispasmodics, anti-cataracts, capillary protectant, unnatural amino acid, anti-hepatitis, anti-parkinsonian, antihistamine, nootropic and anti-diabetics. The company was founded on December 17, 1998 and is headquartered in Hwaseong, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company